The service fees paid out by Medytox during the past 4 years have reached nearly KRW 100 billion. Since 2019, disputes related to botulinum toxin had risen simultaneously in the United States and Korea, which led to an increase in the litigation costs and fees the company has spent.

The amount of annual service fee payouts decreased after the legal dispute in the US ended with a settlement, but with the risk of litigation in Korea and abroad still unresolved, the company has been spending more than KRW 15 billion a year in litigation fees.

◆Company paid KRW 97.7 billion for 4 years since 2019 as service fees due to a surge in litigation costs

According to the Finan